Photo of Todd Korthuis, M.D., M.P.H.

Todd Korthuis M.D., M.P.H.

    • Associate Professor of Medicine, Division of General Internal Medicine and Geriatrics School of Medicine

Dr. Korthuis is a practicing general internist, addiction medicine provider, and clinician scientist. He began his clinical career treating patients living with HIV and became board-certified in addiction medicine in 2010. His research focuses on improving integration of addiction treatment in diverse health care settings, including HIV clinics. He serves as Principal Investigator for two international trials funded by the National Institute on Drug Abuse: The CTN-0055/0067 CHOICES trial of clinic-based extended-release naltrexone in North American HIV clinics, and the BRAVO trial of clinic-based buprenorphine for opioid use disorder in Vietnam HIV clinics. He is co-investigator in the National Institute of Drug Abuse Clinical Trials Network Western States Node, collaborating in clinical trials of opioid, methamphetamine, and cocaine treatment. Honors include the 2008 Lawrence S. Linn Award for research that improves the lives of people living with HIV and a 2012-2013 Fulbright Scholar award to study integration of HIV and addiction care in Vietnam.  Dr. Korthuis serves as Program Director for the OHSU Addiction Medicine Fellowship and Co-Director of the Oregon Addiction Education and Prevention Initiative that provides training and support for rural primary care providers in pharmacotherapy for substance use disorders.

Education

  • M.P.H., University of California at Los Angeles, Los Angeles California 0
  • M.D., University of Health Sciences, Chicago Medical School, Chicago Illinois 0 1997
  • Residency:

    • Internal medicine, Yale University School of Medicine
  • Fellowship:

    • Health services research, VA Ambulatory Care/UCLA Fellowship
  • Certifications:

    • Internal medicine

Memberships and associations

  • Society of General Internal Medicine

Publications

  • "Integrase strand transfer inhibitor-associated diabetes mellitus : A case report." International Journal of STD and AIDS  In: , Vol. 28, No. 6, 01.05.2017, p. 626-628.
  • "“It’s been an Experience, a Life Learning Experience” : A Qualitative Study of Hospitalized Patients with Substance Use Disorders." Journal of General Internal Medicine  In: , Vol. 32, No. 3, 01.03.2017, p. 296-303.
  • "Primary care-based models for the treatment of opioid use disorder : A scoping review." Annals of Internal Medicine  In: , Vol. 166, No. 4, 21.02.2017, p. 268-278.
  • "Comparing longitudinal CD4 responses to cART among non-perinatally HIV-infected youth versus adults : Results from the HIVRN Cohort." PLoS ONE  In: , Vol. 12, No. 2, e0171125, 01.02.2017.
  • "Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics : A pilot/feasibility randomized trial." Addiction  In: , 2017.
  • "HIV patients' preference for integrated models of addiction and HIV treatment in Vietnam." Journal of Substance Abuse Treatment  In: , Vol. 69, 01.10.2016, p. 57-63.
  • "How does decision complexity affect shared decision making? An analysis of patient-provider antiretroviral initiation dialogue." Patient Education and Counseling  In: , 23.09.2016.
  • "Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence : The Cocaine Use Reduction with Buprenorphine (CURB) study." Addiction  In: , Vol. 111, No. 8, 01.08.2016, p. 1416-1427.
  • "Healthcare Coverage for HIV Provider Visits before and after Implementation of the Affordable Care Act." Clinical Infectious Diseases  In: , Vol. 63, No. 3, 01.08.2016, p. 387-395.
  • "Assessing Problematic Substance Use in HIV Care : Which Questions Elicit Accurate Patient Disclosures?" Journal of General Internal Medicine  In: , 19.05.2016, p. 1-7.
  • "A delayed injection-site reaction in a patient receiving extended-release naltrexone." Substance Abuse  In: , Vol. 37, No. 2, 02.04.2016, p. 278-280.
  • "Respecting patients is associated with more patient-centered communication behaviors in clinical encounters." Patient Education and Counseling  In: , Vol. 99, No. 2, 01.02.2016, p. 250-255.
  • "Clinician empathy is associated with differences in patient-clinician communication behaviors and higher medication self-efficacy in HIV care." Patient Education and Counseling  In: , Vol. 99, No. 2, 01.02.2016, p. 220-226.
  • "Quality of HIV Care and Mortality Rates in HIV-Infected Patients." Clinical Infectious Diseases In: , Vol. 62, No. 2, 15.01.2016, p. 233-239.
  • "Which Clinician Questions Elicit Accurate Disclosure of Antiretroviral Non-adherence When Talking to Patients?" AIDS and Behavior  In: , 26.10.2015.
  • "Cumulative incidence of cancer among persons with HIV in North America : A cohort study." Annals of Internal Medicine  In: , Vol. 163, No. 7, 06.10.2015, p. 507-518.
  • "Cumulative Incidence of Cancer Among Persons With HIV in North America : A Cohort Study." Annals of Internal Medicine  In: , Vol. 163, No. 7, 06.10.2015, p. 507-518.
  • "Impact of a brief patient and provider intervention to improve the quality of communication about medication adherence among HIV patients." Patient Education and Counseling In: , Vol. 98, No. 9, 01.09.2015, p. 1078-1083.
  • "The HIV care continuum : Changes over time in retention in care and viral suppression." PLoS One  In: , Vol. 10, No. 6, e0129376, 18.06.2015.
  • "Hospitalization rates and reasons among HIV elite controllers and persons with medically controlled HIV infection." Journal of Infectious Diseases In: , Vol. 211, No. 11, 01.06.2015, p. 1692-1702.
  • "Impact of hepatitis coinfection on healthcare utilization among persons living with HIV." Journal of Acquired Immune Deficiency Syndromes In: , Vol. 68, No. 4, 01.04.2015, p. 425-431.
  • "Gonorrhea and chlamydia testing increasing but still lagging in HIV clinics in the United States." Journal of Acquired Immune Deficiency Syndromes In: , Vol. 70, No. 3, 2015, p. 275-279.
  • "A mixed methods study of patient-provider communication about opioid analgesics." Patient Education and Counseling  In: , Vol. 98, No. 4, 2015, p. 453-461.
  • "Factors associated with willingness to take extended release naltrexone among injection drug users." Addiction science & clinical practice  In: , Vol. 10, 2015, p. 12.
  • "Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals." Oral Oncology  In: , Vol. 50, No. 12, 01.12.2014, p. 1169-1176.
  • "Hepatitis C virus testing in adults living with HIV : A need for improved screening efforts." PLoS One In: , Vol. 9, No. 7, e102766, 17.07.2014.
  • "HIV risk reduction with buprenorphine-naloxone or methadone : Findings from a randomized trial." Journal of Acquired Immune Deficiency Syndromes  In: , Vol. 66, No. 3, 01.07.2014, p. 288-293.
  • "Retention in care is more strongly associated with viral suppression in HIV-infected patients with lower versus higher CD4 counts." Journal of Acquired Immune Deficiency Syndromes In: , Vol. 65, No. 3, 01.03.2014, p. 333-339.
  • "Does this adult patient have early HIV infection? The rational clinical examination systematic review." JAMA - Journal of the American Medical Association In: , Vol. 312, No. 3, 2014, p. 278-285.
  • "Provider-patient communication about adherence to anti-retroviral regimens differs by patient race and ethnicity." AIDS and Behavior In: , Vol. 18, No. 7, 2014, p. 1279-1287.

Additional information

Edit profile